Akela Pharma Inc.
Profile
Mailing Address: 11501 Domain Drive, Suite 130
Austin, Texas
78758
Head Office Address: 11501 Domain Drive, Suite 130
Austin, Texas
78758
Contact Name: Rudy J. Emmelot Principal Regulator: British Columbia
Business e-mail address: EmmelotR@akelapharma.com Short Form Prospectus Issuer: Yes
Telephone Number: 512 531-6676 Reporting Jurisdictions: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, Nova Scotia
Fax Number: 512 339-3050 Stock Exchange: TSX
Date of Formation: Nov 15 1988 Stock Symbol: AKL
Jurisdiction Where Formed: Canada Auditor: Deloitte & Touche
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 00972X Transfer Agent: Equity Transfer and Trust Company
Financial Year-End: Dec 31 Size of Issuer (Assets): $25,000,001 to $100,000,000


View This Company's Documents